http://jcps.bjmu.edu.cn

中国药学(英文版) ›› 2016, Vol. 25 ›› Issue (7): 526-534.DOI: 10.5246/jcps.2016.07.058

• 【研究论文】 • 上一篇    下一篇

液相串联质谱法测定人血浆中选择性β2受体激动剂妥洛特罗的浓度

程龙妹, 郝光涛, 陈学义, 张应福, 张媛媛, 董瑞华, 刘泽源, 曲恒燕*   

  1. 军事医学科学院 附属医院 临床药理学研究室, 北京 100071
  • 收稿日期:2016-02-18 修回日期:2016-04-05 出版日期:2016-07-19 发布日期:2016-04-20
  • 通讯作者: Tel./Fax: +86-010-66947481, E-mail: quhymail@126.com

Quantification of tulobuterol, a selective β2 adrenergic agonist, in human plasma by liquid chromatography-tandem quadrupole mass spectrometry

Longmei Cheng, Guangtao Hao, Xueyi Chen, Yingfu Zhang, Yuanyuan Zhang, Ruihua Dong, Zeyuan Liu, Hengyan Qu*   

  1. Department of Clinical Pharmacology, Affiliated Hospital, the Academy of Military Medical Sciences, Beijing 100071, China
  • Received:2016-02-18 Revised:2016-04-05 Online:2016-07-19 Published:2016-04-20
  • Contact: Tel./Fax: +86-010-66947481, E-mail: quhymail@126.com

摘要:

建立一种简便、高灵敏度的液相串联质谱分析方法测定人血浆中妥洛特罗的浓度。以异丙醇正己烷(5:95, v/v)为提取试剂, 妥洛特罗-d9为内标, 使用300 Extend C18 (4.6 mm×150 mm, 5 µm)为分析柱对妥洛特罗进行分离。流动相为0.1%甲酸水(A)乙腈(B), 等梯度洗脱, 流速为1.0 mL/min, 1:1进行分流。采用多反应监测模式, 正离子扫描对妥洛特罗进行定量分析, 妥洛特罗及内标的定量离子对分别为m/z 228.1→m/z 154.0m/z 237.2→m/z 154.0. 血浆中妥洛特罗线性范围为0.015.0 ng/mL, 定量下限为0.01 ng/mL。日间精密度<3.7%, 日内精密度<11.1%绝对回收率高于66%, 基质效应影响较小。该方法可应用于健康受试者使用妥洛特罗透皮贴剂后的药代动力学研究。

关键词: 妥洛特罗, 液相串联质谱, 人血浆, 药代动力学

Abstract:

A simple and highly sensitive method coupled with liquid chromatography-tandem quadrupole mass spectrometry (LC-MS/MS) was developed and validated for the determination of tulobuterol in human plasma. Sample was preparated by liquid-liquid extraction with i-propanoln-hexane (5:95, v/v). Tulobuterol and tulobuterol-d9 (internal standard, IS) were separatedon a 300 Extend C18 column(4.6 mm×150 mm, 5 µm), using 0.1%formic acid (A)acetonitrile (B) (30:70, v/v) as the mobile phase at the flow rate of 1.0 mL/min with an approximately 1:1 split entering the mass spectrometer. Detection was performed by positive electrospray ionization mass spectrometry multiple reaction monitoring of the precursor-to-product ion transition of tulobuterol at m/z 228.1→m/z 154.0 and tulobuterol-d9 atm/z 237.2→m/z 154.0. The assay was linear over the range 0.015.0 ng/mLwith a lower limit of quantitation of 0.01 ng/mL. The intra- and inter-day precisions were 3.7% and 11.1%, respectively. Recoverywas approximately 66%, and matrix effects were minimal. This method also showed satisfactory sensitivity, specificity, and carryover. The method was successfully applied to a pharmacokinetic study of tulobuterol in healthy volunteers who were given the tulobuterol patch containing 2 mg tulobuterol.

Key words: Tulobuterol, LC-MS/MS, Human plasma, Pharmacokinetic

中图分类号: 

Supporting: